Park Square Financial Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.21K Sell
72
-3
-4% -$167 0.05% 121
2026
Q2
$4.08K Sell
75
-65
-46% -$3.16K 0.04% 135
2026
Q1
$6K Buy
+140
New +$6.02K 0.05% 139
2025
Q4
– Sell
-96
Closed -$3.96K – 265
2025
Q3
$3.96K Sell
96
-104
-52% -$4.18K 0.02% 206
2025
Q2
$8.82K Buy
+200
New +$7.99K 0.01% 621

Other funds holding EXEL

Park Square Financial Group's EXEL Position: Q3 2026 in Review

Park Square Financial Group reduced its Exelixis (EXEL) stake by 4% in Q3 2026, selling an estimated $167 and leaving 72 shares worth $4.21K. The position accounts for 0.05% of the portfolio, ranked #121.

Park Square Financial Group first reported a position in EXEL in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.82K in Q2 2025. 777 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • Park Square Financial Group held 72 shares of Exelixis worth $4.21K as of Q3 2026.
  • Park Square Financial Group sold 3 Exelixis shares in Q3 2026, an estimated $167.
  • Exelixis made up 0.05% of Park Square Financial Group's portfolio in Q3 2026, its #121 holding.
  • Park Square Financial Group first reported a position in Exelixis in Q2 2025 and has held it in 5 quarters since.
  • Park Square Financial Group's Exelixis position peaked at $8.82K in Q2 2025.
  • 777 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on Park Square Financial Group's 13F filing for Q3 2026, filed 9 Nov 2026.